Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Number of holders
-
626
-
Total 13F shares, excl. options
-
47,485,940
-
Shares change
-
+303,308
-
Total reported value, excl. options
-
$17,565,553,473
-
Value change
-
+$159,923,840
-
Put/Call ratio
-
116%
-
Number of buys
-
332
-
Number of sells
-
-260
-
Price
-
$369.92
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2021
694 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2021.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 626 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,485,940 shares
of 50,495,188 outstanding shares and own 94.04% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,911,634 shares), BlackRock Inc. (4,935,011 shares), FMR LLC (2,558,406 shares), STATE STREET CORP (1,898,754 shares), Invesco Ltd. (1,442,785 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,438,409 shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1,397,036 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (978,478 shares), GEODE CAPITAL MANAGEMENT, LLC (876,004 shares), and AMERIPRISE FINANCIAL INC (841,031 shares).
This table shows the top 626 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.